Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study

被引:535
作者
Singanayagam, Anika [1 ,2 ,7 ]
Hakki, Seran [1 ]
Dunning, Jake [5 ,7 ]
Madon, Kieran J. [1 ]
Crone, Michael A. [2 ,4 ,6 ]
Koycheva, Aleksandra [1 ]
Derqui-Fernandez, Nieves [1 ]
Barnett, Jack L. [1 ]
Whitfield, Michael G. [1 ]
Varro, Robert [1 ]
Charlett, Andre [8 ]
Kundu, Rhia [1 ]
Fenn, Joe [1 ]
Cutajar, Jessica [1 ]
Quinn, Valerie [1 ]
Conibear, Emily [1 ]
Barclay, Wendy [2 ]
Freemont, Paul S. [2 ,4 ,6 ]
Taylor, Graham P. [2 ]
Ahmad, Shazaad [9 ]
Zambon, Maria [7 ]
Ferguson, Neil M. [3 ]
Lalvani, Ajit [1 ]
机构
[1] Imperial Coll London, NIHR Hlth Protect Res Unit Resp Infect, Natl Heart & Lung Inst, London W2 1PG, England
[2] Imperial Coll London, Dept Infect Dis, London, England
[3] Imperial Coll London, NIHR Hlth Protect Res Unit Modelling & Hlth Econ, MRC Ctr Global Infect Dis Anal, Jameel Inst, London, England
[4] Imperial Coll London, UK Dementia Res Inst, Ctr Care Res & Technol, London, England
[5] Univ Oxford, NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Oxford, England
[6] Imperial Coll, London Biofoundry, Translat & Innovat Hub, London, England
[7] Publ Hlth England, Natl Infect Serv, London, England
[8] Publ Hlth England, Data & Analyt Serv, London, England
[9] Manchester Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Med Microbiol Partnership, Dept Virol, Manchester, Lancs, England
关键词
D O I
10.1016/S1473-3099(21)00648-4
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background The SARS-CoV-2 delta (B.1.617.2) variant is highly transmissible and spreading globally, including in populations with high vaccination rates. We aimed to investigate transmission and viral load kinetics in vaccinated and unvaccinated individuals with mild delta variant infection in the community. Methods Between Sept 13, 2020, and Sept 15, 2021, 602 community contacts (identified via the UK contract-tracing system) of 471 UK COVID-19 index cases were recruited to the Assessment of Transmission and Contagiousness of COVID-19 in Contacts cohort study and contributed 8145 upper respiratory tract samples from daily sampling for up to 20 days. Household and non-household exposed contacts aged 5 years or older were eligible for recruitment if they could provide informed consent and agree to self-swabbing of the upper respiratory tract. We analysed transmission risk by vaccination status for 231 contacts exposed to 162 epidemiologically linked delta variant-infected index cases. We compared viral load trajectories from fully vaccinated individuals with delta infection (n=29) with unvaccinated individuals with delta (n=16), alpha (B.1.1.7; n=39), and pre-alpha (n=49) infections. Primary outcomes for the epidemiological analysis were to assess the secondary attack rate (SAR) in household contacts stratified by contact vaccination status and the index cases' vaccination status. Primary outcomes for the viral load kinetics analysis were to detect differences in the peak viral load, viral growth rate, and viral decline rate between participants according to SARS-CoV-2 variant and vaccination status. Findings The SAR in household contacts exposed to the delta variant was 25% (95% CI 18-33) for fully vaccinated individuals compared with 38% (24-53) in unvaccinated individuals. The median time between second vaccine dose and study recruitment in fully vaccinated contacts was longer for infected individuals (median 101 days [IQR 74-120]) than for uninfected individuals (64 days [32-97], p=0.001). SAR among household contacts exposed to fully vaccinated index cases was similar to household contacts exposed to unvaccinated index cases (25% [9s% CI 15-35] for vaccinated vs 23% [15-31] for unvaccinated). 12 (39%) of 31 infections in fully vaccinated household contacts arose from fully vaccinated epidemiologically linked index cases, further confirmed by genomic and virological analysis in three index case-contact pairs. Although peak viral load did not differ by vaccination status or variant type, it increased modestly with age (difference of 0.39 [95% credible interval -0.03 to 0.79] in peak log(10) viral load per la between those aged 10 years and 50 years). Fully vaccinated individuals with delta variant infection had a faster (posterior probability >0.84) mean rate of viral load decline (0.95 log(10) copies per mL per day) than did unvaccinated individuals with pre-alpha (0.69), alpha (0.82), or delta (0.79) variant infections. Within individuals, faster viral load growth was correlated with higher peak viral load (correlation 0.42 [95% credible interval 0.13 to 0.65]) and slower decline (-0.44 [-0.67 to -0.18]). Interpretation Vaccination reduces the risk of delta variant infection and accelerates viral clearance. Nonetheless, fully vaccinated individuals with breakthrough infections have peak viral load similar to unvaccinated cases and can efficiently transmit infection in household settings, including to fully vaccinated contacts. Host-virus interactions early in infection may shape the entire viral trajectory. (C) 2021 The Author(s). Published by Elsevier Ltd.
引用
收藏
页码:183 / 195
页数:13
相关论文
共 31 条
[1]   Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant [J].
Bernal, Jamie Lopez ;
Andrews, Nick ;
Gower, Charlotte ;
Gallagher, Eileen ;
Simmons, Ruth ;
Thelwall, Simon ;
Stowe, Julia ;
Tessier, Elise ;
Groves, Natalie ;
Dabrera, Gavin ;
Myers, Richard ;
Campbell, Colin N. J. ;
Amirthalingam, Gayatri ;
Edmunds, Matt ;
Zambon, Maria ;
Brown, Kevin E. ;
Hopkins, Susan ;
Chand, Meera ;
Ramsay, Mary .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (07) :585-594
[2]   Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings - Barnstable County, Massachusetts, July 2021 [J].
Brown, Catherine M. ;
Vostok, Johanna ;
Johnson, Hillary ;
Burns, Meagan ;
Gharpure, Radhika ;
Sami, Samira ;
Sabo, Rebecca T. ;
Hall, Noemi ;
Foreman, Anne ;
Schubert, Petra L. ;
Gallagher, Glen R. ;
Fink, Timelia ;
Madoff, Lawrence C. ;
Gabriel, Stacey B. ;
MacInnis, Bronwyn ;
Park, Daniel J. ;
Siddle, Katherine J. ;
Harik, Vaira ;
Arvidson, Deirdre ;
Brock-Fisher, Taylor ;
Dunn, Molly ;
Kearns, Amanda ;
Laney, A. Scott .
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (31) :1059-1062
[3]   SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis [J].
Cevik, Muge ;
Tate, Matthew ;
Lloyd, Ollie ;
Maraolo, Alberto Enrico ;
Schafers, Jenna ;
Ho, Antonia .
LANCET MICROBE, 2021, 2 (01) :E13-E22
[4]  
Challen R., 2021, EARLY EPIDEMIOLOGICA, DOI DOI 10.1101/2021.06.05.21258365
[5]   Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study [J].
Chia, Po Ying ;
Ong, Sean Wei Xiang ;
Chiew, Calvin J. ;
Ang, Li Wei ;
Chavatte, Jean-Marc ;
Mak, Tze-Minn ;
Cui, Lin ;
Kalimuddin, Shirin ;
Chia, Wan Ni ;
Tan, Chee Wah ;
Chai, Louis Yi Ann ;
Tan, Seow Yen ;
Zheng, Shuwei ;
Lin, Raymond Tzer Pin ;
Wang, Linfa ;
Leo, Yee-Sin ;
Lee, Vernon J. ;
Lye, David Chien ;
Young, Barnaby Edward .
CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (04) :612.e1-612.e7
[6]   Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study [J].
Chung, Hannah ;
He, Siyi ;
Nasreen, Sharifa ;
Sundaram, Maria E. ;
Buchan, Sarah A. ;
Wilson, Sarah E. ;
Chen, Branson ;
Calzavara, Andrew ;
Fell, Deshayne B. ;
Austin, Peter C. ;
Wilson, Kumanan ;
Schwartz, Kevin L. ;
Brown, Kevin A. ;
Gubbay, Jonathan B. ;
Basta, Nicole E. ;
Mahmud, Salaheddin M. ;
Righolt, Christiaan H. ;
Svenson, Lawrence W. ;
MacDonald, Shannon E. ;
Janjua, Naveed Z. ;
Tadrous, Mina ;
Kwong, Jeffrey C. .
BMJ-BRITISH MEDICAL JOURNAL, 2021, 374
[7]   BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting [J].
Dagan, Noa ;
Barda, Noam ;
Kepten, Eldad ;
Miron, Oren ;
Perchik, Shay ;
Katz, Mark A. ;
Hernan, Miguel A. ;
Lipsitch, Marc ;
Reis, Ben ;
Balicer, Ran D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (15) :1412-1423
[8]   Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021 [J].
de Gier, Brechje ;
Andeweg, Stijn ;
Joosten, Rosa ;
ter Schegget, Ronald ;
Smorenburg, Naomi ;
van de Kassteele, Jan ;
Hahne, Susan J. M. ;
van den Hof, Susan ;
de Melker, Hester E. ;
Knol, Mirjam J. .
EUROSURVEILLANCE, 2021, 26 (31)
[9]  
Elliott P, REACT 1 ROUND 13 FIN
[10]   Modeling the impact on virus transmission of Wolbachia-mediated blocking of dengue virus infection of Aedes aegypti [J].
Ferguson, Neil M. ;
Duong Thi Hue Kien ;
Clapham, Hannah ;
Aguas, Ricardo ;
Vu Tuan Trung ;
Tran Nguyen Bich Chau ;
Popovici, Jean ;
Ryan, Peter A. ;
O'Neill, Scott L. ;
McGraw, Elizabeth A. ;
Vo Thi Long ;
Le Thi Dui ;
Nguyen, Hoa L. ;
Nguyen Van Vinh Chau ;
Wills, Bridget ;
Simmons, Cameron P. .
SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (279)